Arrowhead Pharmaceuticals, Inc. ARWR

Updated: 7 Sep 2026

NASDAQ | Biotech | RNAi therapeutics development

No signal published yet

We already track Arrowhead Pharmaceuticals and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Arrowhead Pharmaceuticals free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
RNAi therapeutics development
We're already tracking Arrowhead Pharmaceuticals, Inc. — here are the latest events we've registered

Recent News

  • In late August 2026, Arrowhead presented Phase 3 SHASTA-3 and SHASTA-4 study results for plozasiran at the European Society of Cardiology Congress. Results demonstrated median triglyceride reductions of up to 81% and a 78% reduction in acute pancreatitis events compared to placebo in patients with severe hypertriglyceridemia. The company plans to submit a supplemental New Drug Application to the U.S. FDA by the end of 2026.

What Firelda Watch includes for Arrowhead Pharmaceuticals, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Arrowhead Pharmaceuticals, Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Boozt AB (publ)
BOOZT
HOLD
Vitrolife AB (publ)
VITR
HOLD
Lagercrantz Group
LAGR B
NEUTRAL
Tetra Tech, Inc.
TTEK
HOLD
Vicore Pharma Holding AB (publ)
VICO
HOLD

Biotech

More companies in this sector

Want to follow Arrowhead Pharmaceuticals, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Arrowhead Pharmaceuticals free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Arrowhead Pharmaceuticals, Inc. ARWR
Arrowhead Pharmaceuticals — follow and we'll monitor it
Follow Arrowhead Pharmaceuticals free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.